Literature DB >> 17387167

Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Ana M Aguirre-Blanco1, Pauline T Lukey, Jacqueline M Cliff, Hazel M Dockrell.   

Abstract

Three commonly used Mycobacterium bovis BCG vaccine strains elicited different magnitudes of T-cell activation and gamma interferon production in vitro in healthy BCG-vaccinated individuals. Glaxo 1077 exhibited the greatest stimulatory capacity, followed by Pasteur 1173 and then Danish 1331. These differences may affect in vitro stimulation and vaccination-induced immunogenicity.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17387167      PMCID： PMC1932901          DOI： 10.1128/IAI.01611-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  23 in total

Review 1.  BCG--different strains, different vaccines?

Authors:  Marcel A Behr
Journal:  Lancet Infect Dis       Date:  2002-02       Impact factor: 25.071

2.  The in vitro evolution of BCG vaccines.

Authors:  Serge Mostowy; Anthony G Tsolaki; Peter M Small; Marcel A Behr
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

3.  Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine.

Authors:  Patricia Gorak-Stolinska; Rosemary E Weir; Sian Floyd; Maeve K Lalor; Sally Stenson; Keith Branson; Rose Blitz; Sarah Luke; Bernadette Nazareth; Anne Ben-Smith; Paul E M Fine; Hazel M Dockrell
Journal:  Vaccine       Date:  2006-05-08       Impact factor: 3.641

4.  Strain to strain variation in the immunogenicity of BCG.

Authors:  J M Grange; J A Gibson
Journal:  Dev Biol Stand       Date:  1986

5.  Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects.

Authors:  O Horwitz; K Bunch-Christensen
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

6.  Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains.

Authors:  M Gheorghiu; P H Lagrange
Journal:  Ann Immunol (Paris)       Date:  1983 Jan-Feb

7.  Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.

Authors:  T F Brewer
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

8.  Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns.

Authors:  C Abou-Zeid; I Smith; J Grange; J Steele; G Rook
Journal:  J Gen Microbiol       Date:  1986-11

9.  Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70.

Authors:  K Miura; S Nagai; M Kinomoto; S Haga; T Tokunaga
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence.

Authors:  F M Collins
Journal:  Tubercle       Date:  1985-12
View more
  4 in total

Review 1.  T cells in mycobacterial infection and disease.

Authors:  Andrea M Cooper
Journal:  Curr Opin Immunol       Date:  2009-07-29       Impact factor: 7.486

2.  Different transcriptional profiles of human monocyte-derived dendritic cells infected with distinct strains of Mycobacterium tuberculosis and Mycobacterium bovis bacillus Calmette-Guérin.

Authors:  Nunzia Sanarico; Alessia Colone; Manuela Grassi; Viviana Speranza; Daniela Giovannini; Antonio Ciaramella; Vittorio Colizzi; Francesca Mariani
Journal:  Clin Dev Immunol       Date:  2011-03-22

3.  Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency.

Authors:  Suleiman Al-Hammadi; Ahmed R Alsuwaidi; Eman T Alshamsi; Ghassan A Ghatasheh; Abdul-Kader Souid
Journal:  BMC Res Notes       Date:  2017-05-05

4.  Deep sequencing analysis of the heterogeneity of seed and commercial lots of the bacillus Calmette-Guérin (BCG) tuberculosis vaccine substrain Tokyo-172.

Authors:  Takayuki Wada; Fumito Maruyama; Tomotada Iwamoto; Shinji Maeda; Taro Yamamoto; Ichiro Nakagawa; Saburo Yamamoto; Naoya Ohara
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.